Cargando…
Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation
AIMS: It is recommended to perform atrial fibrillation ablation with continuous anticoagulation. Continuous apixaban has not been tested. METHODS AND RESULTS: We compared continuous apixaban (5 mg b.i.d.) to vitamin K antagonists (VKA, international normalized ratio 2–3) in atrial fibrillation patie...
Autores principales: | Kirchhof, Paulus, Haeusler, Karl Georg, Blank, Benjamin, De Bono, Joseph, Callans, David, Elvan, Arif, Fetsch, Thomas, Van Gelder, Isabelle C, Gentlesk, Philip, Grimaldi, Massimo, Hansen, Jim, Hindricks, Gerhard, Al-Khalidi, Hussein R, Massaro, Tyler, Mont, Lluis, Nielsen, Jens Cosedis, Nölker, Georg, Piccini, Jonathan P, De Potter, Tom, Scherr, Daniel, Schotten, Ulrich, Themistoclakis, Sakis, Todd, Derick, Vijgen, Johan, Di Biase, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110196/ https://www.ncbi.nlm.nih.gov/pubmed/29579168 http://dx.doi.org/10.1093/eurheartj/ehy176 |
Ejemplares similares
-
Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillation
por: Piccini, Jonathan P, et al.
Publicado: (2020) -
Predictors of recurrence of atrial fibrillation within the first 3 months after ablation
por: Zink, Matthias Daniel, et al.
Publicado: (2020) -
Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial
por: Ezekowitz, Michael D, et al.
Publicado: (2018) -
Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial
por: Willems, Stephan, et al.
Publicado: (2021) -
Post-embryonic Hourglass Patterns Mark Ontogenetic Transitions in Plant Development
por: Drost, Hajk-Georg, et al.
Publicado: (2016)